相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kinetics of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor
William M. Pardridge
PHARMACEUTICALS (2022)
Pharmacological property, mechanism of action and clinical study results of Pabinafusp Alfa (Genetical Recombination) (IZCARGO® I.V. Infusion 10 mg) as the therapeutic for Mucopolysaccharidosis type-II (Hunter syndrome)
Ryuji Yamamoto et al.
Folia Pharmacologica Japonica (2022)
Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies
Rebecca Faresjo et al.
PHARMACEUTICAL RESEARCH (2022)
A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
Torayuki Okuyama et al.
MOLECULAR THERAPY (2021)
Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil
Roberto Giugliani et al.
MOLECULAR THERAPY (2021)
Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
Ryuji Yamamoto et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
Examination of a blood-brain barrier targeting 8-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis
Michael J. Przybilla et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2021)
Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
William M. Pardridge et al.
PHARMACEUTICALS (2021)
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
Julie C. Ullman et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice
Jiahong Sun et al.
MOLECULAR PHARMACEUTICS (2019)
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
Torayuki Okuyama et al.
MOLECULAR THERAPY (2019)
Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery
Ruben J. Boado et al.
SCIENTIFIC REPORTS (2019)
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
Jiahong Sun et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse-Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2018)
Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I
William M. Pardridge et al.
BIODRUGS (2018)
A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
Hiroyuki Sonoda et al.
MOLECULAR THERAPY (2018)
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Roberto Giugliani et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor
William M. Pardridge et al.
MOLECULAR PHARMACEUTICS (2018)
Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease
Rudy Chang et al.
MOLECULAR PHARMACEUTICS (2018)
Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease
Rudy Chang et al.
MOLECULAR PHARMACEUTICS (2017)
Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2017)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2016)
Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2016)
Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo
Michael B. Tropak et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
Cara M. Weismann et al.
HUMAN MOLECULAR GENETICS (2015)
Insulin Receptor Antibody-Iduronate 2-Sulfatase Fusion Protein: Pharmacokinetics, Anti-Drug Antibody, and Safety Pharmacology in Rhesus Monkeys
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Insulin Receptor Antibody-Sulfamidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
Darren A. Murrey et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
IgG-Enzyme Fusion Protein: Pharmacokinetics and Anti-Drug Antibody Response in Rhesus Monkeys
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2013)
Blood-Brain Barrier Molecular Trojan Horse Enables Imaging of Brain Uptake of Radioiodinated Recombinant Protein in the Rhesus Monkey
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2013)
Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Combination stroke therapy in the mouse with blood-brain barrier penetrating IgG-GDNF and IgG-TNF decoy receptor fusion proteins
Rachita K. Sumbria et al.
BRAIN RESEARCH (2013)
Quantitative Atlas of Blood-Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
Yutaro Hoshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Disaggregation of Amyloid Plaque in Brain of Alzheimer's Disease Transgenic Mice with Daily Subcutaneous Administration of a Tetravalent Bispecific Antibody That Targets the Transferrin Receptor and the Abeta Amyloid Peptide
Rachita K. Sumbria et al.
MOLECULAR PHARMACEUTICS (2013)
Pharmacokinetics and Brain Uptake of an IgG-TNF Decoy Receptor Fusion Protein Following Intravenous, Intraperitoneal, and Subcutaneous Administration in Mice
Rachita K. Sumbria et al.
MOLECULAR PHARMACEUTICS (2013)
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Imaging Amyloid Plaque in Alzheimer's Disease Brain with a Biotinylated Aβ Peptide Radiopharmaceutical Conjugated to an IgG-Avidin Fusion Protein
Rachita K. Sumbria et al.
BIOCONJUGATE CHEMISTRY (2012)
Brain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion protein
Rachita K. Sumbria et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A
Jie Bu et al.
MOLECULAR THERAPY (2012)
A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
Sachiko Ohshima-Hosoyama et al.
PLOS ONE (2012)
Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin Receptor
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2012)
Brain-Penetrating IgG-Iduronate 2-Sulfatase Fusion Protein for the Mouse
Qing-Hui Zhou et al.
DRUG METABOLISM AND DISPOSITION (2012)
Delivery of a Peptide Radiopharmaceutical to Brain with an IgG-Avidin Fusion Protein
Qing-Hui Zhou et al.
BIOCONJUGATE CHEMISTRY (2011)
Expression in CHO Cells and Pharmacokinetics and Brain Uptake in the Rhesus Monkey of an IgG-Iduronate-2-Sulfatase Fusion Protein
Jeff Zhiqiang Lu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein
Ailing Fu et al.
BRAIN RESEARCH (2011)
Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse
Qing-Hui Zhou et al.
BRAIN RESEARCH (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Receptor-Mediated Abeta Amyloid Antibody Targeting to Alzheimer's Disease Mouse Brain
Qing-Hui Zhou et al.
MOLECULAR PHARMACEUTICS (2011)
Reversal of Lysosomal Storage in Brain of Adult MPS-I Mice with Intravenous Trojan Horse-Iduronidase Fusion Protein
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2011)
Neuroprotection with a Brain-Penetrating Biologic Tumor Necrosis Factor Inhibitor
Qing-Hui Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Chronic Dosing of Mice with a Transferrin Receptor Monoclonal Antibody-Glial-Derived Neurotrophic Factor Fusion Protein
Qing-Hui Zhou et al.
DRUG METABOLISM AND DISPOSITION (2011)
Genetic Engineering of a Bifunctional IgG Fusion Protein with Iduronate-2-Sulfatase
Jeff Zhiqiang Lu et al.
BIOCONJUGATE CHEMISTRY (2010)
IgG-Single Chain Fv Fusion Protein Therapeutic for Alzheimer's Disease: Expression in CHO Cells and Pharmacokinetics and Brain Delivery in the Rhesus Monkey
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein
Ailing Fu et al.
BRAIN RESEARCH (2010)
Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier
Ailing Fu et al.
BRAIN RESEARCH (2010)
Monoclonal Antibody-Glial-Derived Neurotrophic Factor Fusion Protein Penetrates the Blood-Brain Barrier in the Mouse
Qing-Hui Zhou et al.
DRUG METABOLISM AND DISPOSITION (2010)
Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Genetic engineering of IgG-glucuronidase fusion proteins
Ruben J. Boado et al.
JOURNAL OF DRUG TARGETING (2010)
Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
Ruben J. Boado et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin Receptor
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2010)
Re-Engineering Erythropoietin as an IgG Fusion Protein That Penetrates the Blood-Brain Barrier in the Mouse
Qing-Hui Zhou et al.
MOLECULAR PHARMACEUTICS (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood-Brain Barrier Delivery in the Mouse
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
Donna M. Wilcock et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Comparison of Blood-Brain Barrier Transport of Glial-Derived Neurotrophic Factor (GDNF) and an IgG-GDNF Fusion Protein in the Rhesus Monkey
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2009)
Effects of Etanercept and Minocycline in a rat model of spinal cord injury
Fabien Marchand et al.
EUROPEAN JOURNAL OF PAIN (2009)
AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase β-subunit deficiency
Allison M. Bradbury et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery
William M. Pardridge et al.
PHARMACEUTICAL RESEARCH (2009)
Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2008)
Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
William M. Pardridge
BIOCONJUGATE CHEMISTRY (2008)
GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
A New Generation of Neurobiological Drugs Engineered to Overcome the Challenges of Brain Drug Delivery
Ruben J. Boado
DRUG NEWS & PERSPECTIVES (2008)
Depression, comorbidities and the TNF-α system
H. Himmerich et al.
EUROPEAN PSYCHIATRY (2008)
Sanfilippo syndrome: A mini-review
M. J. Valstar et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology
Chun-Fang Xia et al.
PHARMACEUTICAL RESEARCH (2007)
Neuroprotection by erythropoietin administration after experimental traumatic brain injury
Giovanni Grasso et al.
BRAIN RESEARCH (2007)
Biological and clinical effects of anti-TNFα treatment
G. Valesini et al.
AUTOIMMUNITY REVIEWS (2007)
TNF-α inhibition as a treatment strategy for neurodegenerative disorders:: New drug candidates and targets
David Tweedie et al.
CURRENT ALZHEIMER RESEARCH (2007)
Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Murine model (Galnstm(C76S)slu) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins
Shunji Tomatsu et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease
Y.-Q. Xue et al.
NEUROSCIENCE (2007)
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and Aβ fibril disaggregation
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2007)
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
Patrick P. Ng et al.
BLOOD (2006)
Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment
Chiara Rossi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and future
Judith A. Hobert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats
Tohru Kobayashi et al.
STROKE (2006)
Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy
C Sevin et al.
HUMAN MOLECULAR GENETICS (2006)
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease
KL Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Motoneurons crave glial cell line-derived neurotrophic factor
MC Bohn
EXPERIMENTAL NEUROLOGY (2004)
Enzyme-replacement therapy for metabolic storage disorders
RO Brady et al.
LANCET NEUROLOGY (2004)
Differential expression patterns of TrkB ligands in the macaque monkey brain
T Mori et al.
NEUROREPORT (2004)
Gene therapy progress and prospects: gene therapy of lysosomal storage disorders
SH Cheng et al.
GENE THERAPY (2003)
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells
PP Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins
T Linke et al.
BIOLOGICAL CHEMISTRY (2001)
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
